Showing results (51-60 of 66) with videos related to
Sort By:
Pageof 7
Bone Marrow Transplantation|January 10, 2002
Phase II trial of high-dose intravenous doxorubicin, etoposide, and cyclophosphamide with autologous stem cell support in patients with residual or responding recurrent ovarian cancerR J Morgan, J H Doroshow, L Leong, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 7, 2012
Long-term survival after high-dose chemotherapy followed by peripheral stem cell rescue for high-risk, locally advanced/inflammatory, and metastatic breast cancerA VanderWalde, W Ye, P Frankel, et al.Blood|March 1, 1997
Effect of CD34+ selection and various schedules of stem cell reinfusion and granulocyte colony-stimulating factor priming on hematopoietic recovery after high-dose chemotherapy for breast cancerG Somlo, I Sniecinski, T Odom-Maryon, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2001
Tandem-cycle high-dose melphalan and cisplatin with peripheral blood progenitor cell support in patients with breast cancer and other malignanciesG Somlo, W Chow, V Hamasaki, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
High-dose infusional doxorubicin and cyclophosphamide: a feasibility study of tandem high-dose chemotherapy cycles without stem cell supportR J Morgan, J H Doroshow, K Venkataraman, et al.International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 17, 2007
Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium TrialR J Morgan, T W Synold, D Gandara, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 21, 2016
Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre studyG A McArthur, M Maio, A Arance, et al.Cancer Research|July 14, 1998
Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysisR J Morgan, E M Newman, J H Doroshow, et al.Blood|April 27, 1999
Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapyG Somlo, I Sniecinski, A ter Veer, et al.Leukemia|December 22, 1999
Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionD S Snyder, A P Nademanee, M R O'Donnell, et al.Pageof 7